Feb 23, 2021
The final episode summarizes the human data on complement in ANCA vasculitis, with a quick discussion of the trials of C5a receptor antagonism.
Brought to you by Actemra.
Feb 3, 2021
This episode walks us through the initial research that paved the way for a game changing therapeutic in ANCA vasculitis, as well as the story of how host Adam J. Brown, MD, finally learned how to spell complement.
Brought to you by GSK. Considering a treatment change for patients with active SLE? Learn about a...